The fusion gene BCR::ABL1 (resulting from a translocation between chromosomes 9 and 22) acts as a marker for mutant cells responsible for CML and is capable of inducing the disease in mice4. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.